National Metastatic Colorectal Cancer Awareness Day is observed each year on March 13 to bring attention to metastatic colorectal cancer (mCRC), a form of colorectal cancer that has spread beyond the colon or rectum to other parts of the body, most commonly the liver or lungs.
Metastatic colorectal cancer is considered stage IV disease and remains one of the most challenging forms of cancer to treat. While there is currently no universal cure, scientific progress is rapidly expanding treatment possibilities. Many patients are living longer through a combination of approaches including surgery, systemic therapies such as chemotherapy, immunotherapy and targeted treatments, interventional procedures, and participation in clinical trials. These advancements continue to transform what is possible for patients facing metastatic disease.
National Metastatic Colorectal Cancer Awareness Day shines a light on the urgent need for continued research, innovation, and patient advocacy to improve outcomes and expand options for those living with metastatic colorectal cancer.
Observed during Colorectal Cancer Awareness Month, this day also recognizes the strength of the metastatic community and the importance of collaboration across patients, caregivers, clinicians, researchers, and advocacy organizations working together to drive progress.
This awareness effort is made possible through partnership and shared commitment with Takeda Oncology, Exelixis, Sirtex Medical, Ackerman Properties, Colon Cancer Stars, Diversified Management Plus, GI Cancers Alliance, The Interventional Initiative, Jacqueline Rush Lynch Syndrome Cancer Foundation, Kando, Love is the Answer, Lynch Syndrome Awareness, Man Up To Cancer, My Faulty Gene, One Cancer Place, Raymond Foundation, Right Scan Right Time, WunderGlo, YogaBridge, Yoon Healthcare Services, and many dedicated advocacy partners helping amplify the voices of those living with metastatic colorectal cancer.
Together, we ELEVATE awareness, ADVOCATE for progress, and STAND WITH every patient navigating metastatic disease.
